February 21, 2024

Alverno's February 2024 Test Bulletin delivers essential updates for healthcare providers. Included are enhancements to the Client Community interface, an automated process for Cyclic Citrullinated Peptide Antibody testing, updates to Catecholamines Plasma testing, and discontinuation of certain Quest tests. Additionally, Alverno introduces Polymedco’s FIT, an automated CRC screening tool, aiming to increase screening rates via targeted patient outreach and partnerships with healthcare organizations like Ascension Health Medical Group and BCBS.